Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 6.53.
Forward PE Ratio (6.53) = Close Price ($16.32) / Consensus Forward EPS ($2.50)
FORWARD PE RATIO
6.53
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-67.21%
vs the sector median at left
Viatris Inc.
Market Cap
$19.01B
Forward PE Ratio
6.53
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Viatris Inc. (VTRS) | $19.01B | 6.53 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $19.54B | 11.84 |
| Medpace Holdings, Inc. (MEDP)vs › | $17.33B | 35.27 |
| United Therapeutics Corporation (UTHR)vs › | $21.78B | 19.63 |
| Solventum Corporation (SOLV)vs › | $15.51B | 12.51 |
| The Cooper Companies, Inc. (COO)vs › | $14.87B | 16.46 |
| STERIS plc (STE)vs › | $23.19B | 23.33 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | 26.08 |
| Revvity, Inc. (RVTY)vs › | $13.92B | 23.29 |
| Baxter International Inc. (BAX)vs › | $13.62B | 12.83 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
6.5
consensus next-FY EPS
At today's $16.32 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $2.50 | $2.47 – $2.53 | 5 | 6.5x |
| 2027-12-31 | $2.68 | $2.61 – $2.77 | 5 | 6.1x |
| 2028-12-31 | $2.90 | $1.83 – $3.98 | 2 | 5.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
